1.
Cai Y, Wang J-Y, Bai C. Clinical Studies on conformal radiotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitor in second-line treatment of non-small cell lung cancer. Trop. J. Pharm Res [Internet]. 2016 May 30 [cited 2026 Oct. 6];15(5):1053-60. Available from: https://www.ajol.info/index.php/tjpr/article/view/136364